$1,325$1,630 weight FDA-approved for: Type 2 diabetes (Victoza)
Auristatin-based payloads, such as the conventional monomethyl auristatin E (MMAE), are exceptionally potent microtubule inhibitors with IC 50 values typically ranging from 10 to 100 pM against various cancer cell lines
Like GLP-1, it enhances glucose-dependent insulin secretion
To re-establish the heptad pattern to strengthen the hydrophobic interaction between the helices, N709 was mutated to valine (Fig
However, understanding potential risks enables informed decision-making
Utilizing USFDA-approved technology, we ensure safe and effective procedures personalised for individual needs